vs

Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and ORASURE TECHNOLOGIES INC (OSUR). Click either name above to swap in a different company.

ORASURE TECHNOLOGIES INC is the larger business by last-quarter revenue ($26.8M vs $23.6M, roughly 1.1× GENCOR INDUSTRIES INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -72.1%, a 86.7% gap on every dollar of revenue. On growth, GENCOR INDUSTRIES INC posted the faster year-over-year revenue change (-25.0% vs -28.5%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-9.9M). Over the past eight quarters, GENCOR INDUSTRIES INC's revenue compounded faster (-23.9% CAGR vs -29.7%).

Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

GENC vs OSUR — Head-to-Head

Bigger by revenue
OSUR
OSUR
1.1× larger
OSUR
$26.8M
$23.6M
GENC
Growing faster (revenue YoY)
GENC
GENC
+3.6% gap
GENC
-25.0%
-28.5%
OSUR
Higher net margin
GENC
GENC
86.7% more per $
GENC
14.6%
-72.1%
OSUR
More free cash flow
GENC
GENC
$20.1M more FCF
GENC
$10.1M
$-9.9M
OSUR
Faster 2-yr revenue CAGR
GENC
GENC
Annualised
GENC
-23.9%
-29.7%
OSUR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GENC
GENC
OSUR
OSUR
Revenue
$23.6M
$26.8M
Net Profit
$3.4M
$-19.3M
Gross Margin
28.7%
41.0%
Operating Margin
13.2%
-75.1%
Net Margin
14.6%
-72.1%
Revenue YoY
-25.0%
-28.5%
Net Profit YoY
-9.8%
-78.7%
EPS (diluted)
$0.23
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENC
GENC
OSUR
OSUR
Q4 25
$23.6M
$26.8M
Q3 25
$18.8M
$27.1M
Q2 25
$27.0M
$31.2M
Q1 25
$38.2M
$29.9M
Q4 24
$31.4M
$37.4M
Q3 24
$20.9M
$39.9M
Q2 24
$25.6M
$54.3M
Q1 24
$40.7M
$54.1M
Net Profit
GENC
GENC
OSUR
OSUR
Q4 25
$3.4M
$-19.3M
Q3 25
$1.9M
$-13.7M
Q2 25
$3.8M
$-19.7M
Q1 25
$6.1M
$-16.0M
Q4 24
$3.8M
$-10.8M
Q3 24
$1.5M
$-4.5M
Q2 24
$2.6M
$-615.0K
Q1 24
$6.2M
$-3.6M
Gross Margin
GENC
GENC
OSUR
OSUR
Q4 25
28.7%
41.0%
Q3 25
24.2%
43.5%
Q2 25
26.5%
42.1%
Q1 25
29.7%
41.1%
Q4 24
27.6%
36.2%
Q3 24
25.6%
42.8%
Q2 24
23.9%
45.4%
Q1 24
30.3%
44.5%
Operating Margin
GENC
GENC
OSUR
OSUR
Q4 25
13.2%
-75.1%
Q3 25
-1.2%
-59.4%
Q2 25
11.6%
-57.7%
Q1 25
17.0%
-59.3%
Q4 24
14.7%
-33.2%
Q3 24
5.9%
-15.0%
Q2 24
7.8%
-5.0%
Q1 24
17.4%
-13.1%
Net Margin
GENC
GENC
OSUR
OSUR
Q4 25
14.6%
-72.1%
Q3 25
10.2%
-50.6%
Q2 25
14.2%
-63.0%
Q1 25
16.0%
-53.6%
Q4 24
12.1%
-28.8%
Q3 24
6.9%
-11.3%
Q2 24
10.0%
-1.1%
Q1 24
15.3%
-6.6%
EPS (diluted)
GENC
GENC
OSUR
OSUR
Q4 25
$0.23
$-0.28
Q3 25
$0.13
$-0.19
Q2 25
$0.26
$-0.26
Q1 25
$0.42
$-0.21
Q4 24
$0.26
$-0.14
Q3 24
$0.10
$-0.06
Q2 24
$0.17
$-0.01
Q1 24
$0.42
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENC
GENC
OSUR
OSUR
Cash + ST InvestmentsLiquidity on hand
$147.7M
$199.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$215.2M
$340.8M
Total Assets
$228.9M
$403.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENC
GENC
OSUR
OSUR
Q4 25
$147.7M
$199.3M
Q3 25
$136.3M
$216.5M
Q2 25
$136.0M
$234.6M
Q1 25
$143.7M
$247.6M
Q4 24
$130.1M
$267.8M
Q3 24
$115.4M
$278.6M
Q2 24
$116.6M
$267.4M
Q1 24
$117.1M
$263.8M
Total Debt
GENC
GENC
OSUR
OSUR
Q4 25
Q3 25
$0
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
Q1 24
Stockholders' Equity
GENC
GENC
OSUR
OSUR
Q4 25
$215.2M
$340.8M
Q3 25
$211.8M
$362.0M
Q2 25
$209.9M
$380.7M
Q1 25
$206.1M
$396.3M
Q4 24
$200.0M
$410.3M
Q3 24
$196.1M
$425.6M
Q2 24
$194.7M
$425.8M
Q1 24
$192.1M
$426.3M
Total Assets
GENC
GENC
OSUR
OSUR
Q4 25
$228.9M
$403.2M
Q3 25
$222.6M
$423.1M
Q2 25
$220.2M
$445.0M
Q1 25
$223.9M
$457.6M
Q4 24
$218.2M
$479.7M
Q3 24
$208.1M
$464.1M
Q2 24
$201.8M
$466.3M
Q1 24
$206.0M
$467.6M
Debt / Equity
GENC
GENC
OSUR
OSUR
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENC
GENC
OSUR
OSUR
Operating Cash FlowLast quarter
$11.1M
$-9.0M
Free Cash FlowOCF − Capex
$10.1M
$-9.9M
FCF MarginFCF / Revenue
43.0%
-37.1%
Capex IntensityCapex / Revenue
4.1%
3.4%
Cash ConversionOCF / Net Profit
3.23×
TTM Free Cash FlowTrailing 4 quarters
$-3.2M
$-53.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENC
GENC
OSUR
OSUR
Q4 25
$11.1M
$-9.0M
Q3 25
$-275.0K
$-10.1M
Q2 25
$-23.9M
$-10.2M
Q1 25
$12.4M
$-19.7M
Q4 24
$14.8M
$109.0K
Q3 24
$-3.2M
$12.7M
Q2 24
$-1.0M
$7.8M
Q1 24
$11.7M
$6.7M
Free Cash Flow
GENC
GENC
OSUR
OSUR
Q4 25
$10.1M
$-9.9M
Q3 25
$-1.3M
$-11.0M
Q2 25
$-24.4M
$-12.2M
Q1 25
$12.3M
$-20.2M
Q4 24
$14.5M
$-347.0K
Q3 24
$-3.3M
$12.5M
Q2 24
$-1.4M
$6.2M
Q1 24
$11.7M
$5.2M
FCF Margin
GENC
GENC
OSUR
OSUR
Q4 25
43.0%
-37.1%
Q3 25
-6.8%
-40.6%
Q2 25
-90.4%
-38.9%
Q1 25
32.2%
-67.3%
Q4 24
46.1%
-0.9%
Q3 24
-15.8%
31.4%
Q2 24
-5.6%
11.5%
Q1 24
28.7%
9.5%
Capex Intensity
GENC
GENC
OSUR
OSUR
Q4 25
4.1%
3.4%
Q3 25
5.4%
3.4%
Q2 25
1.8%
6.2%
Q1 25
0.4%
1.4%
Q4 24
1.0%
1.2%
Q3 24
0.4%
0.4%
Q2 24
1.5%
3.0%
Q1 24
0.0%
2.9%
Cash Conversion
GENC
GENC
OSUR
OSUR
Q4 25
3.23×
Q3 25
-0.14×
Q2 25
-6.24×
Q1 25
2.04×
Q4 24
3.88×
Q3 24
-2.22×
Q2 24
-0.41×
Q1 24
1.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENC
GENC

Segment breakdown not available.

OSUR
OSUR

Product And Services$24.9M93%
Other$1.9M7%

Related Comparisons